Advanced Search
Conferences

Systems Toxicology to Assess Reduced Risk Tobacco Products

Philip Morris International (PMI) is developing a portfolio of potentially reduced-risk tobacco products. We are currently assessing their risk reduction potential and would like to invite you to attend a scientific symposium to preview and discuss our current research in this area on September 8th, 2014 in Edinburgh, UK. This PMI-hosted scientific symposium will be an opportunity to hear about the Systems Toxicology research PMI is conducting to assess these new products and to get your input on our approaches.

Past
  • September 8, 2014

  • Waldorf Astoria Edinburgh – The Caledonian Hotel, 1 Princes Street, Edinburgh EH1 2AB, UK

Schedule

8 September

16:00 to 16:10

C Mathis

Systems Toxicology-Based Assessment of a RRP using Human Organotypic Tissue Cultures of Nasal and Bronchial Epithelium as well as Buccal Mucosa

cmathis eurotox2014 pmi symposium
2835 KB

8 September

16:10 to 16:20

Aqueous cigarette smoke extract promotes the adhesion of monocytic cells to human coronary arterial endothelial cells in direct and indirect-dependent ways

poster cpoussin eurotox 2014
1005 KB

8 September

16:20 to 16:30

C Mathis

Reduced Impact of a Prototypic Modified Risk Tobacco Product Compared with Conventional Cigarette Smoke on Exposed Human and Rat Primary Normal Bronchial Epithelial Cells

poster cmathis eurotox 2014
1566 KB

8 September

16:30 to 16:40

E Bilal

Verification Of Systems Biology Research In The Age Of Collaborative Competition

poster e bilal biopharma
1526 KB

8 September

16:40 to 16:50

I Gonzalez-Suarez

Multiplexed High Content Screening Analysis Reveals Reduced Toxicity Of A Prototypic Modified Risk Tobacco Product (pMRTP) As Compared To A Conventional Cigarette

igonzalez poster sot conference phoenix
642 KB

8 September

16:50 to 17:00

A Mechanistic Study Of Cigarette Smoke-Induced COPD In C57BL/6 Mice: The Impact Of Switching To pMRTP

Coming soon
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

Our RRPs

Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.